Human immunodeficiency virus type 1 (HIV-1) Gag-specific cytotoxic T lymphocyte (CTL) responses were studied in seven seropositive long-term asymptomatic individuals (CDC A1) with stable CD4 counts for more than 8 years. Using a set of partially overlapping peptides covering the whole Gag, five 15–20-mer peptides were found to contain CTL epitopes. Further characterization of these epitopes revealed a new HLA-A25-restricted CTL epitope in p24, p24203–212 ETINEEAAEW. This region of Gag is highly conserved in clades B and D of HIV-1. Naturally occurring amino acid sequences, containing p24203D (consensus HIV-1 clades A, C, F, G and H) or p24204I (HIV-2ROD) were not recognized by CTL recognizing the index peptide. No virus variants with mutations in this sequence were found in peripheral blood mononuclear cells from the HIV-1-infected individual concerned during the 8 year observation period, indicating that the virus had not escaped from the observed CTL response.
BuseyneF.,
McChesneyM.,
PorrotF.,
KovarikS.,
GuyB.,
RiviereY.1993; Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. Journal of Virology 67:694–702
Centers for Disease Control1992; 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41:1–19
CheynierR.,
Langlade-DemoyenP.,
MarescotM. R.,
BlancheS.,
BlondinG.,
Wain-HobsonS.,
GriscelliC.,
VilmerE.,
PlataF.1992; Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. European Journal of Immunology 22:2211–2217
de WolfF.,
GoudsmitJ.,
PaulD. A.,
LangeJ. M.,
HooijkaasC.,
SchellekensP.,
CoutinhoR. A.,
van der NoordaaJ.1987; Risk of AIDS related complex and AIDS in homosexual men with persistant HIV antigenaemia. British Medical Journal 295:569–572
HeeneyJ. L.,
van ElsC.,
de VriesP.,
ten HaaftP.,
OttingN.,
KoornstraW.,
BoesJ.,
DubbesR.,
NiphuisH.,
DingsM.,
CranageM.,
NorleyS.,
JonkerM.,
BontropR. E.,
OsterhausA.1994; Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. Journal of Experimental Medicine 180:769–774
JassoyC.,
JohnsonR. P.,
NaviaB. A.,
WorthJ.,
WalkerB. D.1992; Detection of a vigorous HIV-l-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. Journal of Immunology 149:3113–3119
JohnsonR. P.,
WalkerB. D.1994; Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural protein. Current Topics in Microbiology and Immunology 189:35–63
JohnsonR. P.,
TrochaA.,
YangL.,
MazzaraG. P.,
PanicaliD. L.,
BuchananM. T.,
WalkerB. D.1991; HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. Journal of Immunology 147:1512–1521
KeetI. P.,
KrolA.,
KleinM. R.,
VeugelersP.,
de WitJ.,
RoosM.,
KootM.,
GoudsmitJ.,
MiedemaF.,
CoutinhoR. A.1994; Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4 + cell counts. Journal of Infectious Diseases 169:1236–1243
KleinM. R.,
van BaalenC. A.,
HolwerdaA. M.,
Kerkhof GardeS. R.,
BendeR. J.,
KeetI. P. M.,
Eeftinck-SchattenkerJ. M.,
OsterhausA. D. M. E.,
MiedemaF.1995; Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: Different for rapid progressors and long-term asymptomatics. Journal of Experimental Medicine 181:1365–1372
KoupR. A.,
SafritJ. T.,
CaoY.,
AndrewsC. A.,
McLeodG.,
BorkowskyW.,
FarthingC.,
HoD. D.1994; Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68:4650–4655
MyersG.,
Wain-HobsonS.,
HendersonL. E.,
KorberB.,
JeangK.,
PavlakisG. N.1994Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic and Amino Acid Sequences Los Alamos, N. Mex.; Los Alamos National Laboratory.:
NixonD. F.,
TownsendA. R.,
ElvinJ. G.,
RizzaC. R.,
GallweyJ.,
McMichaelA. J.1988; HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484–487
RautmannG.,
KienyM. P.,
BrandelyR.,
DottK.,
GirardM.,
MontagnierL.,
LecocqJ. P.1989; HIV-1 core proteins expressed from recombinant vaccinia viruses. AIDS Research and Human Retroviruses 5:147–157
RiviereY.,
RobertsonM. N.,
BuseyneF.1994; Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes. Current Topics in Microbiology and Immunology 189:65–74
SchuitemakerH.,
KootM.,
KootstraN. A.,
DercksenM. W.,
de GoedeR. E.,
van SteenwijkR. P.,
LangeJ. M.,
SchattenkerkJ. K.,
MiedemaF.,
TersmetteM.1992; Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. Journal of Virology 66:1354–1360
van BaalenC. A.,
KleinM. R.,
GerettiA. M.,
KeetR. I.,
MiedemaF.,
van ElsC. A.,
OsterhausA. D. M. E.1993; Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8 + T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 7:781–786
van de GriendR. J.,
van KrimpenB. A.,
BolS. J.,
ThompsonA.,
BolhuisR. L.1984; Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. Journal of Immunological Methods 66:285–298
van der BurgS. H.,
KleinM. R.,
van de VeldeC. J. H.,
KastM.,
MiedemaF.,
MeiiefC. J. M.1995; Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121–127